Prostate cancers are detected on the basis of elevated plasmatic levels of prostate-specific antigen (PSA > 4 ng/mL), a serine protease expressed solely in prostate tissue that acts in cancer pathophysiology by cleaving several growth regulatory proteins [44,46,47]. Here, KLK3 is linked to prostate carcinoma.